P. Passera

2.1k total citations
26 papers, 1.5k citations indexed

About

P. Passera is a scholar working on Endocrinology, Diabetes and Metabolism, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, P. Passera has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Ophthalmology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in P. Passera's work include Diabetes Management and Education (12 papers), Diabetes Management and Research (11 papers) and Retinal Diseases and Treatments (9 papers). P. Passera is often cited by papers focused on Diabetes Management and Education (12 papers), Diabetes Management and Research (11 papers) and Retinal Diseases and Treatments (9 papers). P. Passera collaborates with scholars based in Italy, United Kingdom and United States. P. Passera's co-authors include Massimo Porta, Marina Trento, M. Tomalino, M. Bajardi, E Borgo, Franco Cavallo, Piervincenzo Bondonio, G. Grassi, Gian Michele Molinatti and Franco Cavallo and has published in prestigious journals such as Diabetes Care, Diabetes and Diabetologia.

In The Last Decade

P. Passera

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Passera Italy 18 865 497 286 126 124 26 1.5k
Marina Trento Italy 26 1.4k 1.6× 662 1.3× 371 1.3× 260 2.1× 204 1.6× 70 2.3k
Sora Ludwig Canada 21 588 0.7× 339 0.7× 314 1.1× 81 0.6× 20 0.2× 38 2.0k
Tim Welborn Australia 6 1.0k 1.2× 300 0.6× 82 0.3× 200 1.6× 115 0.9× 9 1.8k
Torild Skrivarhaug Norway 29 1.4k 1.6× 123 0.2× 144 0.5× 141 1.1× 37 0.3× 75 2.3k
Kubilay Karşıdağ Türkiye 14 703 0.8× 332 0.7× 107 0.4× 90 0.7× 25 0.2× 38 1.3k
Heiner Claessen Germany 16 367 0.4× 162 0.3× 88 0.3× 33 0.3× 49 0.4× 36 862
Vivek Chaturvedi India 21 298 0.3× 171 0.3× 89 0.3× 46 0.4× 52 0.4× 80 1.4k
Amira M. Youssef Saudi Arabia 19 735 0.8× 262 0.5× 41 0.1× 83 0.7× 123 1.0× 50 1.4k
Valentino Cherubini Italy 24 1.2k 1.4× 116 0.2× 146 0.5× 232 1.8× 52 0.4× 93 2.0k
Farid H. Mahmud Canada 28 895 1.0× 212 0.4× 151 0.5× 160 1.3× 29 0.2× 93 2.1k

Countries citing papers authored by P. Passera

Since Specialization
Citations

This map shows the geographic impact of P. Passera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Passera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Passera more than expected).

Fields of papers citing papers by P. Passera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Passera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Passera. The network helps show where P. Passera may publish in the future.

Co-authorship network of co-authors of P. Passera

This figure shows the co-authorship network connecting the top 25 collaborators of P. Passera. A scholar is included among the top collaborators of P. Passera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Passera. P. Passera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sassi, Francesca, Ilaria Buondonno, Marco Di Stefano, et al.. (2018). Type 2 diabetes affects bone cells precursors and bone turnover. BMC Endocrine Disorders. 18(1). 55–55. 47 indexed citations
2.
Trento, Marina, et al.. (2015). Depression, anxiety and cognitive function in patients with type 2 diabetes: an 8-year prospective observational study. Acta Diabetologica. 52(6). 1157–1166. 30 indexed citations
3.
Trento, Marina, et al.. (2014). Depression, anxiety, cognitive impairment and their association with clinical and demographic variables in people with type 2 diabetes: a 4-year prospective study. Journal of Endocrinological Investigation. 37(1). 79–85. 20 indexed citations
4.
Trento, Marina, P. Passera, Stefano Albani, et al.. (2013). Quality of life, impaired vision and social role in people with diabetes: a multicenter observational study. Acta Diabetologica. 50(6). 873–877. 31 indexed citations
5.
Trento, Marina, et al.. (2011). A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetologica. 49(3). 199–203. 51 indexed citations
6.
Trento, Marina, G. Grassi, P. Passera, et al.. (2010). Carbohydrate counting improves coping ability and metabolic control in patients with Type 1 diabetes managed by Group Care. Journal of Endocrinological Investigation. 34(2). 101–105. 29 indexed citations
7.
Trento, Marina, Luigi Gentile, G. Grassi, et al.. (2010). Rethink Organization to iMprove Education and Outcomes (ROMEO). Diabetes Care. 33(4). 745–747. 123 indexed citations
8.
Trento, Marina, M. Tomelini, E Borgo, et al.. (2008). The locus of control in patients with Type 1 and Type 2 diabetes managed by individual and group care. Diabetic Medicine. 25(1). 86–90. 51 indexed citations
9.
Trento, Marina, Fabio Broglio, Fabrizio Riganti, et al.. (2008). Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetologica. 45(4). 225–229. 81 indexed citations
10.
Gentile, Luigi, G. Grassi, P. Passera, et al.. (2006). The multicentre clinical trial Romeo (Rethink Organization to Improve Education and Outcomes): an opportunity to evaluate applicability and reproducibility of group care and assess its impact on a large patient population.. Diabetes. 55. 45–45.
11.
Trento, Marina, P. Passera, Valerio Miselli, et al.. (2006). Evaluation of the locus of control in patients with type 2 diabetes after long-term management by group care. Diabetes & Metabolism. 32(1). 77–81. 25 indexed citations
12.
Trento, Marina, P. Passera, E Borgo, et al.. (2005). A 3-year prospective randomized controlled clinical trial of group care in type 1 diabetes. Nutrition Metabolism and Cardiovascular Diseases. 15(4). 293–301. 51 indexed citations
13.
Porta, Massimo, Paola Dalmasso, G. Grassi, et al.. (2004). Pre-pubertal onset of type 1 diabetes and appearance of retinopathy. Diabetes & Metabolism. 30(3). 229–233. 10 indexed citations
14.
Trento, Marina, M. Bajardi, E Borgo, et al.. (2002). Perceptions of diabetic retinopathy and screening procedures among diabetic people. Diabetic Medicine. 19(10). 810–813. 28 indexed citations
15.
Trento, Marina, P. Passera, M. Bajardi, et al.. (2002). Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial. Diabetologia. 45(9). 1231–1239. 163 indexed citations
16.
Porta, Massimo, M. Tomalino, Marina Trento, et al.. (1999). Comparison of the cost-effectiveness of three approaches to screening for and treating sight-threatening diabetic retinopathy.. PubMed. 25(1). 44–53. 15 indexed citations
17.
Tomalino, M., et al.. (1995). Incidence of newly-diagnosed retinopathy during screening for eye complications of diabetes. Diabetologia. 38. 45–45. 4 indexed citations
18.
Porta, Massimo, et al.. (1995). Diabetic Retinopathy as a Cause of Blindness in the Province of Turin, North‐west Italy, in 1967–1991. Diabetic Medicine. 12(4). 355–361. 30 indexed citations
19.
Beltramo, Elena, et al.. (1993). The role of endothelium in the pathogenesis of diabetic microangiopathy. Acta Diabetologica. 30(4). 190–200. 16 indexed citations
20.
Porta, Massimo, et al.. (1987). Levels of serum angiotensin-converting enzyme before and after forearm venous stasis in diabetic microangiopathy.. PubMed. 4(3). 117–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026